Wen Wee Ma

16PUBLICATIONS
107CO-AUTHORS
Molecular targetsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 20, 2026
A Seamless Phase I/II Design With Randomization for Biomarker-Guided Oncology Trials.

|Feb 05, 2026
The Impact of Immunotherapy on Incidence of Second Primary Malignancies: A Surrogate for Antitumor Surveillance Activation.

Bridget Adcock, Moaath K Mustafa Ali, Emily C Zabor

|May 07, 2025
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies.

Di Kang, Yanping Wang, Yiwei Lin

|Jan 25, 2025
PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature.

Anusha Agarwal, Chase J Wehrle, Sangeeta Satish

|Sep 28, 2024
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy.

Neda Dadgar, Arun K Arunachalam, Hanna Hong

|Aug 29, 2024
The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.

Chase J Wehrle, Rebecca Panconesi, Sangeeta Satish

Pageof 3

Frequent Collaborators

3 joint publications

Chase J Wehrle

3 joint publications

Robert R McWilliams

2 joint publications

Jennifer J Gile

2 joint publications

Amit Mahipal